🟢 Conexeu Sciences is trading 10.42% up today after multiple scaled-up CXU batches met specifications

Conexeu Sciences is trading 10.42% up at $3.44 after multiple scaled-up batches of its investigational CXU material met predefined specifications.

• The results advance manufacturing and regulatory work for Ten Minute Tissue, a wound-care candidate that has not been cleared or approved.
• The company remains on track for a planned FDA 510(k) submission in the first quarter of 2027.
• Broader markets were higher while biotechnology was down, making sector strength an unlikely explanation for the move.